Glomerular Kidney Disease Management: The Evolving FSGS Treatment Market
Glomerular kidney diseases represent a significant burden on healthcare systems worldwide, with Focal Segmental Glomerulosclerosis being one of the most challenging to manage. The glomerular kidney disease treatment market is experiencing substantial growth, with projections from USD 1.81 billion in 2024 to USD 3.36 billion by 2032, driven by increasing prevalence and therapeutic...
0 Comments 0 Shares 82 Views 0 Reviews